From shortlisting promising candidates to negotiations: How Singapore procured its first COVID-19 vaccine shipment Toggle share menu
Advertisement
From shortlisting promising candidates to negotiations: How Singapore procured its first COVID-19 vaccine shipment
The arrival of the first shipment of COVID-19 vaccines in Singapore has been a long time coming. Deborah Wong meets the teams involved to get a better understanding of the ins and outs of the process. 2 related media assets (image or videos) available. Click to see the gallery.
22 Dec 2020 11:15PM) Share this content
Bookmark
SINGAPORE: When Singapore’s first shipment of COVID-19 vaccines from Pfizer-BioNTech touched down at Changi Airport on Monday (Dec 21), the relief on the tarmac was palpable.
• Sets pace for targeted therapy development among those diagnosed
22 December 2020, Singapore – For over 20 years, the Genetics Service at the KK Women’s and Children’s Hospital (KKH) has been providing clinical care to patients with genetic disorders. In 2014, BRIDGES (Bringing Research Innovations for the Diagnosis of GEnetic diseases in Singapore) was set up, in collaboration with genomic research institutes at SingHealth, Agency for Science, Technology and Research (A STAR) and Duke-NUS to synergise the diagnostic efforts and patient outcome management.
After six years, the KKH has met the goals set out in its BRIDGES programme, achieving 39 per cent in diagnostic yield through identifying more patients with genetic mutations. This result is on par with similar research programmes globally which have a diagnostic yield of 25 to 40 per cent.
Credit: A STAR s Genome Institute of Singapore (GIS)
22 December 2020, Singapore - For over 20 years, the Genetics Service at the KK Women s and Children s Hospital (KKH) has been providing clinical care to patients with genetic
disorders. In 2014, BRIDGES (Bringing Research Innovations for the Diagnosis of GEnetic diseases in Singapore) was set up, in collaboration with genomic research institutes at SingHealth, Agency for Science, Technology and Research (A STAR) and Duke-NUS to synergise the diagnostic efforts and patient outcome management.
After six years, the KKH has met the goals set out in its BRIDGES programme, achieving 39 per cent in diagnostic yield through identifying more patients with genetic mutations. This result is on par with similar research programmes globally which have a diagnostic yield of 25 to 40 per cent.
The Straits Times
Translating medical science from bench to bedside
Singapore celebrated the work of nine outstanding researchers at the President s Science and Technology Awards this year, the highest form of recognition for research scientists and engineers in the country. Mok Qiu Lin and Clara Chong report on their work. Professors Ranga Krishnan, Dario Campana lauded for work in developing new therapies
Professor Ranga Krishnan speaking from the United States in a video screened last Friday at the awards. He received the President s Science and Technology Medal for his role in advancing health and biomedical sciences research in Singapore.ST PHOTO: ALPHONSUS CHERN
A professor who helped lay the groundwork for research into infectious diseases in Singapore was yesterday honoured for his efforts.
Professor Ranga Krishnan, 64, received a medal under the President s Science and Technology Awards - the highest recognition for exceptional research scientists and engineers here - from President Halimah Yacob at the Istana.
Prof Ranga, who is now chairman of the Health Ministry s National Medical Research Council, had helped establish the emerging infectious diseases programme at Duke-NUS Medical School when he was dean from 2008 to 2015.
One of the school s five signature programmes, it has since yielded many breakthroughs during various outbreaks of infectious diseases, including the current Covid-19 pandemic.